Orphan Drug Market Expected to Grow at CAGR of 10.05% to 2019

Research and Markets recently reported that the global orphan drug market is expected to grow at a CAGR of 10.05% from 2015-2019.
According to the firm’s press release:

The market is expected to witness certain emerging trends. Among these is an increased focus on biologics. Biologics are expected to be a preferred treatment option for the medical fraternity, patients, and the families of patients. This in turn will raise the number of treatment-seeking patients, which results in an increase in the overall consumption of medicines.

Click here to view the full press release.